Share
𝕏 Facebook LinkedIn

Extremely low frequency variable electromagnetic fields affect cancer and noncancerous cells in vitro differently: Preliminary study.

PAPER pubmed Electromagnetic biology and medicine 2018 In vitro study Effect: mixed Evidence: Very low

Abstract

The exposure to extremely low frequency electromagnetic field (ELF-EMF) may result in various changes at the cellular level. To identify the effect of ELF-EMF exposure on viability of cells, cancer cells (U87-MG; 143B) and noncancerous cells (BJ; HEK) in exponential growth phase were exposed or sham-exposed to different values of frequency (2, 20, 30, 50 and 60 Hz), different shapes (sinusoidal, square and triangular) and time of exposure (0.5, 1, 2, 3 h) to electromagnetic field. After exposure, viability of cells was detected by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT). We found a different effect of exposition of cancer and noncancerous cells to ELF-EMF on viability of cells. This preliminary study revealed that electro magentic field(EMF) might serve as a potential tool for manipulating viability of cells.

AI evidence extraction

At a glance
Study type
In vitro study
Effect direction
mixed
Population
In vitro cell lines: cancer (U87-MG; 143B) and noncancerous (BJ; HEK) cells in exponential growth phase
Sample size
—
Exposure
ELF · 0.5, 1, 2, 3 h
Evidence strength
Very low
Confidence: 74% · Peer-reviewed: yes

Main findings

Cancer (U87-MG; 143B) and noncancerous (BJ; HEK) cells exposed to ELF-EMF (2, 20, 30, 50, 60 Hz; sinusoidal/square/triangular; 0.5–3 h) showed different effects on cell viability compared with sham exposure.

Outcomes measured

  • Cell viability (MTT assay)

Limitations

  • Preliminary study
  • In vitro design; findings may not translate to in vivo or human health outcomes
  • Sample size and exposure intensity not reported in abstract
  • Direction/magnitude of viability changes not specified in abstract

Suggested hubs

  • elf-emf (0.9)
    Study examines extremely low frequency (2–60 Hz) electromagnetic field exposure effects on cells.
View raw extracted JSON
{
    "study_type": "in_vitro",
    "exposure": {
        "band": "ELF",
        "source": null,
        "frequency_mhz": null,
        "sar_wkg": null,
        "duration": "0.5, 1, 2, 3 h"
    },
    "population": "In vitro cell lines: cancer (U87-MG; 143B) and noncancerous (BJ; HEK) cells in exponential growth phase",
    "sample_size": null,
    "outcomes": [
        "Cell viability (MTT assay)"
    ],
    "main_findings": "Cancer (U87-MG; 143B) and noncancerous (BJ; HEK) cells exposed to ELF-EMF (2, 20, 30, 50, 60 Hz; sinusoidal/square/triangular; 0.5–3 h) showed different effects on cell viability compared with sham exposure.",
    "effect_direction": "mixed",
    "limitations": [
        "Preliminary study",
        "In vitro design; findings may not translate to in vivo or human health outcomes",
        "Sample size and exposure intensity not reported in abstract",
        "Direction/magnitude of viability changes not specified in abstract"
    ],
    "evidence_strength": "very_low",
    "confidence": 0.7399999999999999911182158029987476766109466552734375,
    "peer_reviewed_likely": "yes",
    "keywords": [
        "extremely low frequency",
        "ELF-EMF",
        "electromagnetic field",
        "in vitro",
        "cell viability",
        "MTT",
        "cancer cells",
        "noncancerous cells",
        "U87-MG",
        "143B",
        "BJ",
        "HEK",
        "sham exposure",
        "frequency",
        "waveform"
    ],
    "suggested_hubs": [
        {
            "slug": "elf-emf",
            "weight": 0.90000000000000002220446049250313080847263336181640625,
            "reason": "Study examines extremely low frequency (2–60 Hz) electromagnetic field exposure effects on cells."
        }
    ]
}

AI can be wrong. Always verify against the paper.

AI-extracted fields are generated from the abstract/metadata and may be incomplete or incorrect. This content is for informational purposes only and is not medical advice.

Comments

Log in to comment.

No comments yet.